首页 › 基金 › CVS HEALTH Corp › VGIT

CVS HEALTH Corp 对 VGIT 的持仓历史

VANGUARD INTERMEDIATE

CVS HEALTH Corp 在 Q3 2026 的 13F 申报中披露持有 VGIT(VANGUARD INTERMEDIATE)85,000 股,市值约 US$4.8M,约占其申报组合的 1.12%,在其申报持仓中市值排名第 20 位。 CVS HEALTH Corp 最近 3 个申报季度中有 3 个季度披露了 VGIT 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)85.00K 股
申报持仓市值$4.82M
组合权重1.12%
首次申报Q1 2026
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

CVS HEALTH Corp 对 VGIT 的持仓演变

CVS HEALTH Corp 于 Q1 2026 首次披露 VGIT 持仓:85,000 股(约 US$5.1M)。 在 3 次申报中,CVS HEALTH Corp 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 85,000 股、市值约 US$4.8M。

逐季持仓明细

季度股数金额变化
Q1 2026 85.00K $5.06M 新进
Q2 2026 85.00K $5.01M 持有
Q3 2026 85.00K $4.82M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VGIT 与 13F 数据

VGIT(VANGUARD INTERMEDIATE)的行业分类暂缺。我们追踪的基金中还有 32 只申报持有 VGIT,申报仓位最大的包括:Empower Advisory Group, LLC (US$1.51B), Creative Planning (US$1.29B), SCS Capital Management LLC (US$1.21B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VGIT 的基金

查看 VGIT 的全部基金持有人 →

常见问题

How long has CVS HEALTH Corp held VGIT?

CVS HEALTH Corp has disclosed VGIT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is CVS HEALTH Corp's current position in VGIT?

As of Q3 2026, CVS HEALTH Corp holds 85.00K shares of VGIT (VANGUARD INTERMEDIATE), valued at $4.82M, representing 1.12% of its reported portfolio and ranking #20.

Has CVS HEALTH Corp been buying or selling VGIT?

In the latest 13F filing (Q3 2026), CVS HEALTH Corp held unchanged its position in VGIT.

Which other funds hold VGIT?

Other major institutional holders of VGIT include Empower Advisory Group, LLC, Creative Planning, SCS Capital Management LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.